{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:50:12Z","timestamp":1787115012179,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:00:00Z","timestamp":1454544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.contraception.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T02:45:27Z","timestamp":1455072327000},"page":"202-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg\/0.65 mL): A systematic review"],"prefix":"10.1016","volume":"94","author":[{"given":"Monica V.","family":"Dragoman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Gaffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.02.003_bb0005","first-page":"CD005214","article-title":"Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception","volume":"3","author":"Draper","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2016.02.003_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera\u00ae): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.contraception.2013.07.002","article-title":"Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm","volume":"89","author":"Halpern","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0030","series-title":"WHO Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.contraception.2016.02.003_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2016.02.003_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US preventive services task force: a review of the process","volume":"20S","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2016.02.003_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.contraception.2006.12.009","article-title":"Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104mg\/0.65mL","volume":"75","author":"Westhoff","year":"2007","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2016.02.003_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.contraception.2012.05.148","article-title":"Effect of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women","volume":"86","author":"Segall-Gutierrez","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.contraception.2011.04.016","article-title":"Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use","volume":"85","author":"Segall-Gutierrez","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/13625187.2013.774358","article-title":"A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate","volume":"18","author":"Segall-Gutierrez","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.02.003_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2016.02.003_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.02.003_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1933719114549848","article-title":"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density","volume":"21","author":"Carr","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.contraception.2016.02.003_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.contraception.2013.11.008","article-title":"Preference for Sayana(R) Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial","volume":"89","author":"Polis","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0100","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2006.11.040","article-title":"Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study","volume":"87","author":"Goldstein","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.02.003_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2014.01.022","article-title":"Observational study of the acceptability of sayana(R) press among intramuscular DMPA users in Uganda and Senegal","volume":"89","author":"Burke","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1345\/aph.1E224","article-title":"Implications of pharmaceutical industry funding on clinical research","volume":"39","author":"Lexchin","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2016.02.003_bb0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.02.003_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2012.11.019","article-title":"Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women","volume":"88","author":"Williams","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2011.10.002","article-title":"Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception","volume":"85","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.003_bb0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.contraception.2011.09.015","article-title":"Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability","volume":"85","author":"Prabhakaran","year":"2012","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T13:19:59Z","timestamp":1545916799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415300676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0010782415300676"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.02.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg\/0.65mL): A systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}